Malignant Hyperthermia Mini One Day Conference. Learn the basics on how recognize, diagnose, and treat Malignant Hyperthermia by attending at the "MH Let’s Save a Life” conference on March 29, 2014 from 10 am to 4 pm at Class of '62 Auditorium, University of Rochester located in Rochester, NY. At the event patients and families sit side-by-side with healthcare professionals and students learning about MH from experts affiliated with the Malignant Hyperthermia Association of the United States (MHAUS). Register online at: www.mhaus.org
For healthcare professionals and students, and patients and their families.
Educational credits are available and lunch is included.
Objectives for participants upon completion will be able to: Identify the signs and symptoms of an MH event, Enforce quick treatment regimen for MH event, Explain the response plan for an MH event to other medical staff, State proper patient safety steps to take in preparation for an MH-Susceptible patient, and Discuss MH testing options with patients and assist them in seeking further information.
The inherited muscle disorder Malignant Hyperthermia (MH) is most often triggered by certain anesthetic drugs leading to a life-threatening crisis that requires prompt, specific treatment. In rare cases, MH may also be triggered by heat and exercise. The conference is sponsored by Malignant Hyperthermia Association of the United States (MHAUS) in conjunction with University of Rochester Medical Center (URMC).
Click here to download flyer and map
This activity has been submitted to the Association of periOperative Registered Nurses, Inc. for approval to award contact hours. The Association of periOperative Registered nurses, Inc. is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Activities that are approved by AORN are recognized as continuing education for registered nurses. This recognition does not imply that AORN or the ANCC Commission on Accreditation approves or endorses any product included in the presentation. 4.5 Credits available.
- Healthcare Professionals $60 ea. ($50 for members) $10 Early bird discount ends 2-15-14
- Healthcare Students $50 ea. ($40 for members) $10 Early bird discount ends 2-15--14
- Patients and Families and Friends $20 ea. ($15 for members)
Upon completion of this program, the participants will be able to:
Identify the signs and symptoms of an MH event
Enforce quick treatment regimen for MH event
Explain the response plan for an MH event to other medical staff
State proper patient safety steps to take in preparation for an MH – susceptible patient
Discuss MH testing options with patients and assist them in seeking further information
Video about the MH Mini-Conference:
10:00 - 10:30 a.m. Registration
10:30 - 10:45 a.m. Welcome & Opening Remarks
10:45 - 11:45 a.m. Session One: What Patients and Their Families Need to Know about MH
11:45 - 12:45 p.m. Lunch is included
12:45 - 2:00 p.m. Session two: What’s New and What’s Next in MH
2:00 - 3:00 p.m. Session three: Update on Genetic Counseling: Genetic Counseling for Families with Malignant Hyperthermia
3:00 – 4:00 p.m. Questions & Answers
Session one: Joseph Tobin, MD; Wake Forest Baptist Health, NC; Anesthesiologist, MHAUS Board Member, and MH Hotline Consultant
Session two: Mary Theroux, MD; Alfred I. DuPont Hospital for Children Wilmington, DE; Anesthesiologist, MHAUS Hotline Consultant
Session three: Deanna Steele, MS, CGC; Magee Women’s Hospital Center for Medical Genetics, PA; Genetic Counselor since 1986, and MHAUS Professional Advisory Council Member.
What is Malignant Hyperthermia:
Malignant hyperthermia (MH) is a potentially fatal, inherited disorder usually associated with the administration of certain general anesthetics and/or the drug succinylcholine. The disorder is due to an acceleration of metabolism in skeletal muscle. The signs of MH include muscle rigidity, rapid heart rate, high body temperature, muscle breakdown and increased acid content. Immediate treatment with the drug dantrolene usually reverses the signs of MH. The underlying defect is abnormally increased levels of cell calcium in the skeletal muscle. There is mounting evidence that some patients will also develop MH with exercise and/or on exposure to hot environments. Without proper and prompt treatment with dantrolene sodium, mortality is extremely high. The best way to protect yourself, your family, your patients and facility, is to be prepared before it's too late.
About the Malignant Hyperthermia Association of the United States (MHAUS):
MHAUS was founded families who lost their children to MH or could not find information about MH. In 1981 they found each other - and a doctor performing MH testing – and agreed "to make current information about MH available to all who need it!”
MH is inherited genetic disorder found in an estimated 1 out of 2,000 people. MH is triggered by certain anesthesia and most often experienced in individuals undergoing routine surgery but in rare cases MH can happen without anesthesia. Symptoms include body temperature of up to 107 degrees, muscle rigidity, system-wide organ failure, and possible death.
Today MHAUS provides information and resources to medical and lay communities through conferences, educational materials, ID tags, 24-hour MH Hotline, MHAUS website, and with the help of new chapter groups forming throughout North America.
The mission of MHAUS is to promote optimum care and scientific understanding of MH and related disorders. MH episodes can happen at any time. MHAUS can help you prepare before it’s too late.
Link to List of Nearby Hotels and Map: